CREATE Medicines Expands Targeted In Vivo CAR Platform Through Strategic Research Collaboration and Exclusive License Agreement with Monash University

Broadens CREATE's delivery toolkit with access to Monash's novel LNP chemistries and next-generation targeting technologies. Enables rapid evaluation of diverse binder formats and cell-targeting strategies, accelerating development across multiple immune cell types and therapeutic...